biomarker detection
Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer
The study will recruit 200 non-small cell lung cancer patients, comparing results of the company's ctDNA testing to tissue next-generation sequencing.
Biocartis Receives €1.4M Grant to Develop New Technology for Molecular Surveillance
The grant will support development of next-generation technology for the firm's Idylla platform that would allow for the offline customization of cartridges.
The test relies on using quantitative PCR to target genes encoded by prophages — viruses present in Lyme-causing bacteria, which can be easier to detect than the bacteria itself.
The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions.
Qlucore Raises SEK 30M as it Looks Toward IPO
The Swedish bioinformatics firm sees its greatest growth potential in precision cancer diagnostics as it prepares to go public in the next 12 months.